This panel webinar discusses the importance of clinical supply agility and how to mitigate supply chain risk that comes along with clinical supply decisions.
When the COVID-19 pandemic began, questions arose on how to manage demand and forecasting in the midst of uncertainty. After the first wave, the industry took stock of lessons learned and began to apply those takeaways to mitigate risks moving forward. At the end of 2020, a new risk surfaced on how the sheer numbers of COVID-19 vaccines being manufactured and distributed may impact the clinical supply chain. Will this impact the clinical supply chain of other products, especially those that require cold chain? How should sponsors adjust forecasts to mitigate potential disruptions?